First Time Loading...

MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 7.5 USD 2.6% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one MDXG stock under the Base Case scenario is 6.98 USD. Compared to the current market price of 7.5 USD, MiMedx Group Inc is Overvalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDXG Relative Value
Base Case
6.98 USD
Overvaluation 7%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.4
P/S
P/S
Price to Sales
3.4
vs History
20
vs Industry
72
Median 3Y
2.6
Median 5Y
2.4
Industry
8.1
Forward
3
More Details
23.5
P/E
P/E
Price to Earnings
23.5
vs History
6
vs Industry
7
Median 3Y
-14.6
Median 5Y
-14.2
Industry
26.2
Forward
23.6
More Details
41
P/OCF
P/OCF
Price to OCF
41
vs History
12
vs Industry
4
Median 3Y
-40
Median 5Y
-33.6
Industry
22.6
More Details
97.2
P/FCFE
P/FCFE
Price to FCFE
97.2
vs History
15
vs Industry
2
Median 3Y
-28.6
Median 5Y
-17
Industry
21.3
More Details
7.7
P/B
P/B
Price to Book Value
7.7
vs History
63
vs Industry
11
Median 3Y
7.7
Median 5Y
9
Industry
2.5
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
20
vs Industry
63
Median 3Y
2.5
Median 5Y
2.3
Industry
7.3
Forward
2.9
More Details
4
EV/GP
EV/GP
Enterprise Value to Gross Profit
4
vs History
20
vs Industry
61
Median 3Y
3
Median 5Y
2.8
Industry
9.1
More Details
23.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.2
vs History
39
vs Industry
6
Median 3Y
27.2
Median 5Y
15.2
Industry
4.4
Forward
14.2
More Details
25.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.1
vs History
38
vs Industry
6
Median 3Y
25
Median 5Y
15.1
Industry
4.3
Forward
18.5
More Details
39.7
EV/OCF
EV/OCF
Enterprise Value to OCF
39.7
vs History
12
vs Industry
4
Median 3Y
-37.7
Median 5Y
-32.5
Industry
5.4
More Details
43.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
43.2
vs History
15
vs Industry
4
Median 3Y
-32.7
Median 5Y
-27.2
Industry
3.2
More Details
7.2
EV/IC
EV/IC
Enterprise Value to IC
7.2
vs History
49
vs Industry
28
Median 3Y
7.1
Median 5Y
6.9
Industry
5
More Details

Multiples Across Competitors

MDXG Competitors Multiples
MiMedx Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MiMedx Group Inc
NASDAQ:MDXG
1.1B USD 3.4 23.5 23.2 25.1
US
Abbvie Inc
NYSE:ABBV
284B USD 5.2 58.9 12.8 19.5
US
Amgen Inc
NASDAQ:AMGN
149.1B USD 5.3 22.2 16.5 24.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.1B USD 10.4 28.5 22.8 23.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
102.6B USD 7.8 25.9 17.4 19.1
AU
CSL Ltd
ASX:CSL
133B AUD 6.2 35.4 21.4 26.6
US
Gilead Sciences Inc
NASDAQ:GILD
81.4B USD 3 168.2 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
48B USD 7 -10.2 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.1B USD 3.2 26.6 13.7 17.1
KR
Celltrion Inc
KRX:068270
38.9T KRW 17.9 72.5 44.4 61.1

See Also

Summary
MDXG intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDXG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDXG stock valuation using valuation multiples.
Wall Street Estimates
MDXG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDXG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.